Publications in collaboration with researchers from Hospital Universitario Puerta del Mar (23)

2024

  1. Cardiac resynchronization therapy with triple fusion using the SyncAV dynamic algorithm compared to conventionally optimized biventricular pacing: Results from the multicentric, randomized, double-blinded CRUSTY trial

    Heart Rhythm, Vol. 21, Núm. 12, pp. 2600-2602

2023

  1. Coronary Artery Disease and Prognosis of Heart Failure with Reduced Ejection Fraction

    Journal of Clinical Medicine, Vol. 12, Núm. 8

2022

  1. Prospective application of a bleeding and ischemic risks-adjusted antithrombotic protocol in elderly patients revascularized with everolimus-eluting stents: EPIC05-Sierra75 study

    Journal of Geriatric Cardiology, Vol. 19, Núm. 5, pp. 354-366

  2. Renal Function Impact in the Prognostic Value of Galectin-3 in Acute Heart Failure

    Frontiers in Cardiovascular Medicine, Vol. 9

  3. Serum potassium dynamics during acute heart failure hospitalization

    Clinical Research in Cardiology, Vol. 111, Núm. 4, pp. 368-379

  4. Validation of multiparametric approaches for the prediction of sudden cardiac death in patients with Brugada syndrome and electrophysiological study

    Revista Espanola de Cardiologia, Vol. 75, Núm. 7, pp. 559-567

2021

  1. A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure

    Frontiers in Physiology, Vol. 12

  2. Aplicación prospectiva de un protocolo antitrombótico ajustado a riesgo isquémico/hemorrágico en pacientes mayores de 75 años tratados con stents liberadores de everolimus: Registro SIERRA-75 (EPIC-05)

    REC: Interventional Cardiology, Vol. 3, Núm. 4, pp. 15-15

  3. Consequences of canceling elective invasive cardiac procedures during Covid-19 outbreak

    Catheterization and Cardiovascular Interventions, Vol. 97, Núm. 5, pp. 927-937

  4. Impact of diabetes in patients waiting for invasive cardiac procedures during COVID-19 pandemic

    Cardiovascular Diabetology, Vol. 20, Núm. 1

  5. Ischemic etiology and prognosis in men and women with acute heart failure

    Journal of Clinical Medicine, Vol. 10, Núm. 8

2020

  1. Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience

    Revista Espanola de Cardiologia, Vol. 73, Núm. 12, pp. 994-1002

  2. Prevalence, clinical profile and prognostic implications of interatrial block in patients admitted for heart failure

    REC: CardioClinics, Vol. 55, Núm. 3, pp. 155-164

2019

  1. Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction

    Internal Medicine Journal, Vol. 49, Núm. 12, pp. 1505-1513

  2. Patient-Associated Predictors of 15- and 30-Day Readmission After Hospitalization for Acute Heart Failure

    Current Heart Failure Reports, Vol. 16, Núm. 6, pp. 304-314

2018

  1. Formin Homology 2 Domain Containing 3 (FHOD3) Is a Genetic Basis for Hypertrophic Cardiomyopathy

    Journal of the American College of Cardiology, Vol. 72, Núm. 20, pp. 2457-2467

2017

  1. Mid-range left ventricular ejection fraction: Clinical profile and cause of death in ambulatory patients with chronic heart failure

    International Journal of Cardiology, Vol. 240, pp. 265-270

2015

  1. A simple validated method for predicting the risk of hospitalization for worsening of heart failure in ambulatory patients: The Redin-SCORE

    European Journal of Heart Failure, Vol. 17, Núm. 8, pp. 818-827

2014

  1. Valor pronóstico del índice de masa corporal y el perímetro de cintura en los pacientes con insuficiencia cardiaca crónica (Registro Español REDINSCOR)

    Revista Espanola de Cardiologia, Vol. 67, Núm. 2, pp. 101-106

2013

  1. Differential clinical characteristics and prognosis of intraventricular conduction defects in patients with chronic heart failure

    European Journal of Heart Failure, Vol. 15, Núm. 8, pp. 877-884